5348 related articles for article (PubMed ID: 6241293)
1. Systemic administration of human leukocyte interferon to melanoma patients. III. Increased helper:suppressor cell ratios in melanoma patients during interferon treatment.
Karavodin LM; Golub SH
Nat Immun Cell Growth Regul; 1983-1984; 3(4):193-202. PubMed ID: 6241293
[TBL] [Abstract][Full Text] [Related]
2. Parameters of interferon action: II. Immunological effects of recombinant leukocyte interferon (IFN-alpha 2) in phase I-II trials.
Ernstoff MS; Fusi S; Kirkwood JM
J Biol Response Mod; 1983; 2(6):540-7. PubMed ID: 6607324
[TBL] [Abstract][Full Text] [Related]
3. Parameters of interferon action: I. Immunological effects of whole cell leukocyte interferon (IFN-alpha) in phase I-II trials.
Ernstoff MS; Fusi S; Kirkwood JM
J Biol Response Mod; 1983; 2(6):528-39. PubMed ID: 6363630
[TBL] [Abstract][Full Text] [Related]
4. Systemic administration of human leukocyte interferon to melanoma patients. I. Effects on natural killer function and cell population.
Golub SH; Dorey F; Hara D; Morton DL; Burk MW
J Natl Cancer Inst; 1982 May; 68(5):703-10. PubMed ID: 6175787
[TBL] [Abstract][Full Text] [Related]
5. Comparative study on the effects of recombinant alpha-2 interferon on immune function in patients with disseminated melanoma.
Hersey P; Coates A; Rallings M; Hall C; MacDonald M; Spurling A; Edwards A; McCarthy WH; Milton GW
J Biol Response Mod; 1986 Jun; 5(3):236-49. PubMed ID: 3487622
[TBL] [Abstract][Full Text] [Related]
6. Systemic administration of human leukocyte interferon to melanoma patients. II. Cellular events associated with changes in natural killer cytotoxicity.
Golub SH; D'Amore P; Rainey M
J Natl Cancer Inst; 1982 May; 68(5):711-7. PubMed ID: 6175788
[TBL] [Abstract][Full Text] [Related]
7. [Multidisciplinary therapy using interferon and immunological evaluation for glioma patients: two-color analysis of T cell subsets].
Numa Y; Kawamoto K; Matsumura H
No Shinkei Geka; 1991 Feb; 19(2):121-8. PubMed ID: 1708857
[TBL] [Abstract][Full Text] [Related]
8. Suppression of human NK cell cytotoxicity by an MLC-Generated cell population.
D'Amore PJ; Golub SH
J Immunol; 1985 Jan; 134(1):272-9. PubMed ID: 3155463
[TBL] [Abstract][Full Text] [Related]
9. [Deficit of natural killer cells (NK cells) in the peripheral blood of patients with atopic dermatitis].
Reinhold U; Wehrmann W; Bauer R; Kreysel HW
Hautarzt; 1986 Aug; 37(8):438-43. PubMed ID: 2944856
[TBL] [Abstract][Full Text] [Related]
10. Immunomodulation by methimazole therapy in Graves' disease: rapid changes in activation stage of circulating regulatory T cell subsets, B cells and NK cells.
Karlsson FA; Tötterman TH
Clin Exp Immunol; 1988 Nov; 74(2):258-63. PubMed ID: 2906281
[TBL] [Abstract][Full Text] [Related]
11. The decrease in non-specific suppressor T lymphocytes in female hyperthyroid Graves' disease is secondary to the hyperthyroidism.
Gerstein HC; Rastogi B; Iwatani Y; Iitaka M; Row VV; Volpé R
Clin Invest Med; 1987 Jul; 10(4):337-44. PubMed ID: 2888555
[TBL] [Abstract][Full Text] [Related]
12. Lymphocyte profiles in patients with chronic low back pain enrolled in a clinical trial.
Brennan PC; Graham MA; Triano JJ; Hondras MA; Anderson RJ
J Manipulative Physiol Ther; 1994 May; 17(4):219-27. PubMed ID: 8046277
[TBL] [Abstract][Full Text] [Related]
13. Intraperitoneal administration of human recombinant interferon-alpha in patients with ovarian cancer: effects on lymphocyte phenotype and cytotoxicity.
Lichtenstein A; Spina C; Berek JS; Jung T; Zighelboim J
Cancer Res; 1988 Oct; 48(20):5853-9. PubMed ID: 3167841
[TBL] [Abstract][Full Text] [Related]
14. Natural killer cell function and modulation by alpha IFN and IL2 in AIDS patients and prodromal subjects.
Lew F; Tsang P; Solomon S; Selikoff IJ; Bekesi JG
J Clin Lab Immunol; 1984 Jul; 14(3):115-21. PubMed ID: 6237206
[TBL] [Abstract][Full Text] [Related]
15. Natural killer cell activity in tumor-draining lymph nodes: investigations in patients with malignant melanoma and head and neck cancer.
Micksche M; Vinzenz K; Kokoschka EM; Kokoschka R
Nat Immun Cell Growth Regul; 1985; 4(6):315-27. PubMed ID: 4088287
[TBL] [Abstract][Full Text] [Related]
16. Normal values of peripheral lymphocyte populations and T cell subsets at a fixed time of day: a flow cytometric analysis with monoclonal antibodies in 210 healthy adults.
Ohta Y; Fujiwara K; Nishi T; Oka H
Clin Exp Immunol; 1986 Apr; 64(1):146-9. PubMed ID: 2942319
[TBL] [Abstract][Full Text] [Related]
17. A large subpopulation of lymphocytes with T helper phenotype (Leu-3/T4+) exhibits the property of binding to NK cell targets and granular lymphocyte morphology.
Velardi A; Grossi CE; Cooper MD
J Immunol; 1985 Jan; 134(1):58-64. PubMed ID: 3155472
[TBL] [Abstract][Full Text] [Related]
18. Suppressor cell function of human granular lymphocytes identified by the HNK-1 (Leu 7) monoclonal antibody.
Tilden AB; Abo T; Balch CM
J Immunol; 1983 Mar; 130(3):1171-5. PubMed ID: 6218202
[TBL] [Abstract][Full Text] [Related]
19. Recombinant interleukin 2 enhanced natural killer cell-mediated cytotoxicity in human lymphocyte subpopulations expressing the Leu 7 and Leu 11 antigens.
Lanier LL; Benike CJ; Phillips JH; Engleman EG
J Immunol; 1985 Feb; 134(2):794-801. PubMed ID: 3871216
[TBL] [Abstract][Full Text] [Related]
20. [Effect of interferon-alpha (MOR-22) on human NK cell activity].
Yanagihara Y; Tochizawa S; Ishii K; Hirai Y
Gan To Kagaku Ryoho; 1986 Feb; 13(2):342-8. PubMed ID: 3947110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
